Sangamo Therapeutics Announces Presentation At The 2017 Wedbush PacGrow Healthcare Conference

12:10 EDT 10 Aug 2017 | PR Newswire

RICHMOND, Calif., Aug. 10, 2017 /PRNewswire/ --Sangamo Therapeutics, Inc. (Nasdaq: SGMO) announced today that Sandy Macrae, M.B., Ch.B., Ph.D., Sangamo's chief executive officer, will present at the 2017 Wedbush PacGrow Healthcare Conference on Tuesday, August 15th at 9:45 a.m. Eastern Time. The conference is being held in New York from August 15-16, 2017.

The presentation will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investor and Media section under Events and Presentation. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo TherapeuticsSangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic therapies that transform patients' lives using the Company's industry leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. For more information about Sangamo, visit

View original content with multimedia:

SOURCE Sangamo Therapeutics, Inc.


More From BioPortfolio on "Sangamo Therapeutics Announces Presentation At The 2017 Wedbush PacGrow Healthcare Conference"

Quick Search

Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...